Literature DB >> 9618737

European drug information centres--survey of activities.

H Müllerová1, J Vlcek.   

Abstract

A questionnaire survey of European drug information centres (DICs) was conducted. DICs mentioned in the ESCP directories and other sources were identified and contacted. Information on basic characteristics was obtained: affiliation, the scope of activities, employees, question-answer service characteristics, information sources and the economic aspects of the DICs' work. Information from 84 DICs was analysed (return rate = 71.3%). DICs are mainly affiliated to hospitals (68%), rather rarely with faculties of pharmacy (6%) or with faculties of medicine (8.3%). Activities of DICs mainly include: question-answer service (98%), issue of bulletins (68%), participation in P&T committees (63%), tuition (61%) and drug-use evaluation (52%). Pharmacists, 1-2 full- or part-time, are the most frequent employees working in the DICs. When the question-answer service was analysed, it was found that 56% of the DICs are open only to the health-care professionals and 43% provide a service to the lay public. Questions are mainly concerned with the side effects, indication/therapeutic use and the dosage of the drugs. The majority of DICs (91%) document their activities, very often on a computer database. Quality assurance is provided by almost 75% of DICs, usually by a review (58%) or a feed-back questionnaire (32%). Information sources listed as most frequently used include Martindale--The Extrapharmacopeia, journals such as Lancet, Medline and Micromedex databases. DICs are usually financially supported by the organizations to whom they are affiliated. Fees are charged, for special activities, by 9.5% of DICs.

Mesh:

Year:  1998        PMID: 9618737     DOI: 10.1023/a:1008672311674

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  3 in total

1.  Current status of drug information centers.

Authors:  S L Beaird; R M Coley; K A Crea
Journal:  Am J Hosp Pharm       Date:  1992-01

2.  Pharmacist-operated drug information centers in the United States.

Authors:  J M Rosenberg; R J Fuentes; C H Starr; H L Kirschenbaum; H McGuire
Journal:  Am J Health Syst Pharm       Date:  1995-05-01       Impact factor: 2.637

3.  European survey of independent drug information centers.

Authors:  N Taggiasco; B Sarrut; C G Doreau
Journal:  Ann Pharmacother       Date:  1992-03       Impact factor: 3.154

  3 in total
  6 in total

1.  Italian drug information centres: benchmark report.

Authors:  D Scala; A Bracco; S Cozzolino; A Cristinziano; C De Marino; A Di Martino; E Gonzalez; A Mancini; F Romagnuolo; L Zeuli
Journal:  Pharm World Sci       Date:  2001-12

2.  Evaluation of tools to prevent drug incompatibilities in paediatric and neonatal intensive care units.

Authors:  Isabella De Giorgi; Bertrand Guignard; Caroline Fonzo-Christe; Pascal Bonnabry
Journal:  Pharm World Sci       Date:  2010-06-17

3.  Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports.

Authors:  Christine Njuguna; Annemie Stewart; Johannes P Mouton; Marc Blockman; Gary Maartens; Annoesjka Swart; Briony Chisholm; Jackie Jones; Mukesh Dheda; Ehimario U Igumbor; Karen Cohen
Journal:  Drug Saf       Date:  2016-02       Impact factor: 5.606

4.  Drug information center: challenges of the research process to answer enquiries in hospital pharmaceutical practices.

Authors:  Damiana da Rocha Vianna Flôres; Alexandre Augusto de Toni Sartori; Julia Borges Antunes; Alessandra Nunes Pinto; Julia Pletsch; Tatiane da Silva Dal Pizzol
Journal:  Eur J Hosp Pharm       Date:  2018-03-22

5.  A two-year utilization of the pharmacist-operated drug information center in Iran.

Authors:  Taher Entezari-Maleki; Mohammad Taraz; Mohammad Reza Javadi; Mir Hamed Hajimiri; Kaveh Eslami; Iman Karimzadeh; Maysam Esmaeili; Kheirollah Gholami
Journal:  J Res Pharm Pract       Date:  2014-10

6.  Operating a patient medicines helpline: a survey study exploring current practice in England using the RE-AIM evaluation framework.

Authors:  Matt Williams; Abbie Jordan; Jenny Scott; Matthew D Jones
Journal:  BMC Health Serv Res       Date:  2018-11-20       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.